Healthtech funding in 2011
European Healthtech startup funding raised during 2011.
In 2011, 63 European Healthtech companies closed 66 funding rounds and raised €528M in equity funding (excluding debt and grants). Switzerland led by capital raised, and Sunstone Capital was the most active investor. Data as of 6 Nov 2026.
Equity funding
€528M
excl. debt & grants
Funding rounds
66
Companies
63
Top country
Switzerland
Healthtech: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2009 | €277M | +263.8% | 26 | +73.3% | — |
| 2010 | €346M | +24.9% | 45 | +73.1% | — |
| 2011 | €528M | +52.8% | 66 | +46.7% | — |
Rank among sectors
#1
14.1% of sector funding
Top-10 round share
62.7%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2011 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €30M | 6 |
| Feb | €140M | 4 |
| Mar | €18M | 8 |
| Apr | €30M | 3 |
| May | €44M | 9 |
| Jun | €46M | 11 |
| Jul | €11M | 1 |
| Aug | €18M | 4 |
| Sep | €24M | 5 |
| Oct | €47M | 6 |
| Nov | €107M | 6 |
| Dec | €16M | 3 |
Top countries
by € raisedHealthtech — top countries by capital, 2011 — interactive chart.
Data table
| Healthtech — top countries by capital, 2011 | |
|---|---|
| Switzerland | €120M |
| Denmark | €114M |
| UK | €112M |
| Austria | €33M |
| Germany | €31M |
| Israel | €27M |
| Sweden | €24M |
| France | €24M |
Stage mix
by € raisedHealthtech — stage mix, 2011 — interactive chart.
Data table
| Healthtech — stage mix, 2011 | |
|---|---|
| Series D+ | €146M |
| Series C | €98M |
| Growth/Late | €70M |
| Series B | €61M |
| Other | €57M |
| Series A | €55M |
| Early VC | €36M |
| Seed | €4.2M |
| Grant | €1.7M |
Exits & M&A
2 Acquisition · 1 Buyout3 exits · €1.0B disclosed.
| BioVex | Acquisition | Jan 2011 | €909M |
| Advanced Accelerator Applications | Buyout | Oct 2011 | €41M |
Largest equity rounds
by disclosed amount, 2011| Company | Stage | Date | Amount |
|---|---|---|---|
| Symphogen | Series D+ | Feb 2011 | €100M |
| Biocartis | Series C | Nov 2011 | €71M |
| CellNovo | Series B | Feb 2011 | €35M |
| Oxford Nanopore Technologies | Series D+ | Apr 2011 | €28M |
| AFFiRiS | Growth/Late | Nov 2011 | €25M |
| Sphere Medical Holding | Growth/Late | Oct 2011 | €18M |
| Anergis | Series A | Mar 2011 | €14M |
| Orphazyme | Series A | Sep 2011 | €14M |
| GenKyoTex | Series C | May 2011 | €14M |
| BONESUPPORT | Growth/Late | Jun 2011 | €13M |
Top investors
most active in 2011, by deal count- Sunstone Capital3 deals
- Bayern Kapital2 deals
- Enterprise Ireland2 deals
- KFW2 deals
- Novo Holdings2 deals
- Accelerace1 deals
- ACT Venture Capital1 deals
- Advent Venture Partners1 deals
- Aescap1 deals
- Artemis1 deals
Source: Tech.eu Funding Explorer · data as of 6 Nov 2026 · licence CC BY 4.0 · Methodology